Does Insurance, HSA, or FSA Cover Medical Marijuana? (2026)

Published June 10, 2026 · Reviewed against the primary sources cited below

No — health insurance, Medicare, and Medicaid do not cover medical cannabis, and IRS rules currently block HSA/FSA spending on it. The April 2026 rescheduling created a crack in that wall, but as of June 2026 the IRS hasn't moved. Here's the precise state of play, because this is where bad information costs people real money.

What the IRS actually says

IRS Publication 502 is explicit: amounts paid for controlled substances such as marijuana that aren't legal under federal law can't be included as medical expenses — even where state law legalizes them. That language governs HSA, FSA, and the Schedule A medical deduction alike. The 2025 edition, still current as of June 2026, retains it unchanged despite the April 2026 rescheduling of state-licensed medical cannabis to Schedule III. Until the IRS updates its guidance, treat cannabis purchases as non-qualified — paying with HSA funds risks the 20% penalty plus income tax on the distribution.

What you generally CAN pay with HSA/FSA funds: the telehealth evaluation itself, as a medical consultation with a licensed physician. Many patients successfully use HSA/FSA cards for the visit fee. Keep documentation; plan administrators vary.

Why insurance won't cover it (yet)

Insurers cover FDA-approved drugs; cannabis flower and dispensary products aren't FDA-approved as drugs, so there's nothing for a formulary to list. The FDA-approved cannabinoids — Epidiolex (CBD) for specific seizure disorders, dronabinol and nabilone for chemotherapy nausea — ARE covered by many plans when prescribed. If your condition fits one of those approvals, that's the insured route.

The rescheduling's real financial effect lands on dispensaries: state-licensed operators escaped IRC 280E, which had barred ordinary business deductions and inflated effective tax rates dramatically. Whether those savings reach patient prices is a market question — worth watching through 2026–27.

The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law. Laws cited here change; confirm current rules with the linked primary sources before acting on them.

FAQ

Quick answers

Can I pay for the doctor's evaluation with my HSA?

Usually yes — a physician consultation is a qualified medical expense regardless of what's discussed. The cannabis products themselves are the non-qualified part.

Could HSA eligibility change soon?

Possibly. State-licensed medical marijuana became Schedule III in April 2026, undermining Pub 502's 'not legal under federal law' rationale for that category — but the IRS hadn't updated guidance as of June 2026. Don't spend HSA funds on cannabis until it does.

Is the card fee itself deductible?

Registration fees paid to a state are a gray area; the physician evaluation has the stronger claim as a medical expense. Ask a tax professional rather than guessing.

Sources & references

IRS Publication 502 — Medical and Dental Expenses (Controlled Substances section) — Internal Revenue Service, 2025.
Schedules of Controlled Substances: Rescheduling of FDA-Approved Products Containing Marijuana From Schedule I to Schedule III (Final Rule, 91 FR 22714) — DEA / Federal Register, 2026.April 28, 2026 final rule: FDA-approved products and state-licensed medical marijuana moved to Schedule III; other marijuana remains Schedule I
What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD — U.S. Food and Drug Administration, 2020.FDA stance, approved cannabinoid drugs (Epidiolex, dronabinol, nabilone), safety risks